← Back to patent-cliff list
CAS 1927914-79-1
butan-1-aminium (E)-3-(3-hydroxy-4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)acrylate
Codes: DX1002
Application context (from source-drug indications)
Hepatocellular carcinomaDX1002食管胃结合部肿瘤DX1002Gastric cancerDX1002Liver cancerDX1002Solid tumourDX1002
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| DX1002 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
butan-1-aminium (E)-3-(3-hydroxy-4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)acrylate→2-(3,4,5-trimethoxyphenyl)acetic acid→2,3-dihydroxy-4-methoxybenzaldehyde→(E)-3-(3-hydroxy-4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)acrylic acid→butan-1-amine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.